PD-1 Antikörper
-
- Target Alle PD-1 (PDCD1) Antikörper anzeigen
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PD-1 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Aufreinigung
- Purified from cell culture supertant by affinity chromatography
- Klon
- UMAB199
- Isotyp
- IgG2a
- Top Product
- Discover our top product PDCD1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
-
-
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." in: Journal of the National Cancer Institute, Vol. 110, Issue 3, pp. 316-320, (2019) (PubMed).
: "Mycoplasma bovis-Induced Inhibition of Bovine Peripheral Blood Mononuclear Cell Proliferation Is Ameliorated after Blocking the Immune-Inhibitory Programmed Death 1 Receptor." in: Infection and immunity, Vol. 86, Issue 3, (2018) (PubMed).
: "
-
Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." in: Journal of the National Cancer Institute, Vol. 110, Issue 3, pp. 316-320, (2019) (PubMed).
-
- Target
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
- Andere Bezeichnung
- Cd279,pd1 (PDCD1 Produkte)
- Synonyme
- CD279 antikoerper, PD-1 antikoerper, PD1 antikoerper, SLEB2 antikoerper, hPD-1 antikoerper, hPD-l antikoerper, Ly101 antikoerper, Pdc1 antikoerper, programmed cell death 1 antikoerper, PDCD1 antikoerper, Pdcd1 antikoerper
- Pathways
- Cancer Immune Checkpoints
-